featured
Nivolumab vs Chemotherapy in Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab Versus Chemotherapy in Patients With Advanced Melanoma Who Progressed After Anti-CTLA-4 Treatment (CheckMate 037): A Randomised, Controlled, Open-Label, Phase 3 Trial
Lancet Oncol 2015 Mar 17;[EPub Ahead of Print], JS Weber, SP D'Angelo, D Minor, FS Hodi, R Gutzmer, B Neyns, C Hoeller, NI Khushalani, WH Miller, CD Lao, GP Linette, L Thomas, P Lorigan, KF Grossmann, JC Hassel, M Maio, M Sznol, PA Ascierto, P Mohr, B Chmielowski, A Bryce, IM Svane, JJ Grob, AM Krackhardt, C Horak, A Lambert, AS Yang, J LarkinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.